Endemic hepatitis e in the Czech Republic

Clinical Infectious Diseases

Volumn 58, Issue 4, 2014, Pages 509-516

  Chalupa, Pavel ^a   Vasickova, Petra ^b   Pavlik, Ivo ^b   Holub, Michal ^a  

^a UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^b VETERINARY RESEARCH INSTITUTE   (Czech Republic)

Author keywords

clinical findings; endemic cases; hepatitis E; zoonosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RIBAVIRIN; VIRUS RNA; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G;

ACUTE HEPATITIS; ACUTE LIVER FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASYMPTOMATIC INFECTION; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; COOKING; CZECH REPUBLIC; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FOOD INTAKE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS ELISA KIT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LIVER DISEASE; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MEAT; MEDICAL HISTORY; MIDDLE AGED; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAW MEAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TASTE; THROMBOCYTE COUNT; TREATMENT CONTRAINDICATION; VIRUS DETECTION; WESTERN BLOTTING; BLOOD; CLASSIFICATION; DNA SEQUENCE; ENZYME IMMUNOASSAY; FECES; GENETICS; ISOLATION AND PURIFICATION; PATHOLOGY; SERUM; VIROLOGY;

ADULT; AGED; CZECH REPUBLIC; ENDEMIC DISEASES; FECES; FEMALE; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SERUM;

EID: 84893217961     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit782     Document Type: Article

References (35)

1. Carstens EB. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009). Arch Virol 2010; 155:133-46.
2. Drexler JF, Seelen A, Corman VM, et al. Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J Virol 2012; 86:9134-47.
3. Khuroo MS. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res 2011; 161:3-14.
4. Lu L, Li CH, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16:5-36.
5. Vasickova P, Psikal I, Kralik P, Widen F, Hubalek Z, Pavlik I. Hepatitis E virus: a review. Vet Med (Praha) 2007; 52:365-84.
6. Hakze-van der Honing RW, van Coillie E, Antonis AF, van der Poel WH. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PLoS One 2011; 6: e22673.
7. Tesse S, Lioure B, Fornecker L, et al. Circulation of genotype 4 hepatitis E virus in Europe: first autochthonous hepatitis E infection in France. J Clin Virol 2012; 54:197-200.
8. Chalupa P, Holub M. Jaundice complicated by an atypical form of Guillain-Barre syndrome. J Clin Virol 2010; 49:229-30.
9. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012; 367:1237-44.
10. Aggarwal R, Jameel S. Hepatitis E. Hepatology 2011; 54:2218-26.
11. Borgen K, Herremans T, Duizer E, et al. Non-travel related hepatitis E virus genotype 3 infections in Netherlands; a case series 2004-2006. BMC Infect Dis 2008; 8:61.
12. Mansuy JM, Peron JM, Abravanel F, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004; 74:419-24.
13. Wichmann O, Schimanski S, Koch J, et al. Phylogenetic and casecontrol study on hepatitis E virus infection in Germany. J Infect Dis 2008; 198: 1732-41.
14. The National Institute of Public Health in Prague. Incidence of chosen infectious diseases in the Czech Republic in the years 2003-2012. Available at: http://www.szu.cz/publikace/data/vybrane-infekcni-nemoci-vcr-v-letech-2003-2012- absolutne. Accessed 12 December 2013.
15. Vasickova P, Slany M, Chalupa P, Holub M, Svoboda R, Pavlik I. Detection and phylogenetic characterization of human hepatitis E virus strains, Czech Republic. Emerg Infect Dis 2011; 17:917-19.
16. Vasickova P, Kralik P, Slana I, Pavlik I. Optimisation of a triplex RTPCR for detection of hepatitis E virus RNA and validation on biological samples. J Virol Meth 2012; 180:38-42.
17. Vasickova P, Psikal I, Widen F, et al. Detection and genetic characterisation of hepatitis E virus in Czech pig production herds. Res Vet Sci 2009; 87:143-48.
18. Khudyakov Y, Kamili S. Serological diagnostics of hepatitis E virus infection. Vir Res 2011; 161:84-92.
19. Favorov MO, Fields HA, Purdy MA, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992; 36:246-25.
20. Bryan JP, Tsarev SA, Iqbal M, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 1994; 170:517-21.
21. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology and prevention. J Med Virol 2008; 80:646-58.
22. Krawczynski K, Meng XJ, Rybczynska J. Pathogenetic elements of hepatitis E and animal models of HEV infection. Vir Res 2011; 161:78-83.
23. Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286:1869-78.
24. Chalupa P, Holub M. Favorable outcome of severe acute hepatitis B in a patient treated with antithrombin III and antiviral therapy. Clin Infect Dis 2009; 49:481.
25. Dalton HR, Hazeldine S, Banks M, Liaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369:1260.
26. Ramachandran J, Eapen CE, Kang G, et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004; 19:134-8.
27. Inoue J, Nishizawa T, Takahashi M, et al. Analysis of the full-length geonome of genotype 4 hepatitis E virus isolates from patients with fulminant or acute self-limited hepatitis E. J Med Virol 2006; 78:476-84.
28. Peron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007; 14:298-303.
29. Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008; 20:784-90.
30. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010; 139:1612-18.
31. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case report sof ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153:85-9.
32. Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011; 52:60-2.
33. Aggarwal R. Hepatitis E: historical, contemporary and future perspectives. J Gastroent Hepatol 2011; 26(suppl 1):72-82.
34. Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 2006; 16:79-83.
35. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E. Emerg Infect Dis 2007; 13:648-9.